These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29067694)

  • 1. Administration of platelet concentrates suspended in bicarbonated Ringer's solution in children who had platelet transfusion reactions.
    Kobayashi J; Yanagisawa R; Ono T; Tatsuzawa Y; Tokutake Y; Kubota N; Hidaka E; Sakashita K; Kojima S; Shimodaira S; Nakamura T
    Vox Sang; 2018 Feb; 113(2):128-135. PubMed ID: 29067694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of administration of platelet concentrates suspended in M-sol or BRS-A for pediatric patients.
    Kojima S; Yanagisawa R; Tanaka M; Nakazawa Y; Shimodaira S
    Transfusion; 2018 Dec; 58(12):2952-2958. PubMed ID: 30291756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS-A in adult patients.
    Yamanaka M; Yanagisawa R; Kojima S; Nakazawa H; Shimodaira S
    Transfusion; 2019 Nov; 59(11):3405-3412. PubMed ID: 31532542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro analysis of volume-reduced washed platelet concentrates stored in bicarbonated Ringer's solution containing less than 5% residual plasma.
    Oikawa S; Minegishi M; Endo K; Kawashima W; Suzuki K; Shimizu H
    Vox Sang; 2016 Jul; 111(1):16-21. PubMed ID: 26918327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replaced platelet concentrates containing a new additive solution, M-sol: safety and efficacy for pediatric patients.
    Yanagisawa R; Shimodaira S; Kojima S; Nakasone N; Ishikawa S; Momose K; Honda T; Yoshikawa K; Saito S; Tanaka M; Nakazawa Y; Sakashita K; Shiohara M; Akino M; Hirayama J; Azuma H; Koike K
    Transfusion; 2013 Sep; 53(9):2053-60. PubMed ID: 23252617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion outcome for volume- and plasma-reduced platelet concentrates for pediatric patients.
    Tanaka M; Yanagisawa R; Yamanaka M; Konno S; Takemura K; Kojima S; Okura E; Morita D; Saito S; Komori K; Matsuzawa H; Sakashita K; Tozuka M; Nakazawa Y
    Transfus Apher Sci; 2020 Aug; 59(4):102776. PubMed ID: 32561112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing adverse reactions in pediatric transfusions using washed platelet concentrate.
    Yanagisawa R
    Pediatr Int; 2021 Apr; 63(4):391-403. PubMed ID: 33290634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Storage of washed platelets in BRS-A platelet additive solutions based on two types of clinically available bicarbonated Ringer's solutions with different electrolyte concentrations.
    Oikawa S; Taguchi T; Endo K; Hoshi T; Kawashima W; Horibe Y; Urano S; Suzuki K; Minegishi M; Itoh T; Shimizu H
    Transfus Apher Sci; 2015 Oct; 53(2):233-7. PubMed ID: 26025656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors related to allergic transfusion reactions and febrile non-haemolytic transfusion reactions in children.
    Yanagisawa R; Shimodaira S; Sakashita K; Hidaka Y; Kojima S; Nishijima F; Hidaka E; Shiohara M; Nakamura T
    Vox Sang; 2016 May; 110(4):376-84. PubMed ID: 26808840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro evaluation of apheresis platelets stored with 100% plasma versus bicarbonated Ringer's solution with less than 5% plasma.
    Oikawa S; Sasaki D; Kikuchi M; Sawamura Y; Itoh T
    Transfusion; 2013 Mar; 53(3):655-60. PubMed ID: 22804481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol).
    Azuma H; Hirayama J; Akino M; Miura R; Kiyama Y; Imai K; Kasai M; Koizumi K; Kakinoki Y; Makiguchi Y; Kubo K; Atsuta Y; Fujihara M; Homma C; Yamamoto S; Kato T; Ikeda H
    Transfusion; 2009 Feb; 49(2):214-8. PubMed ID: 18798806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study.
    de Wildt-Eggen J; Nauta S; Schrijver JG; van Marwijk Kooy M; Bins M; van Prooijen HC
    Transfusion; 2000 Apr; 40(4):398-403. PubMed ID: 10773049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Released washed platelet concentrates are effective and safe in patients with a history of transfusion reactions.
    Fujiwara SI; Fujishima N; Kanamori H; Ito M; Sugimoto T; Saito S; Sakaguchi T; Nagai K; Masuoka H; Nagai K; Morita A; Kino S; Tanaka A; Hasegawa Y; Yokohama A; Fujino K; Makino S; Matsumoto M; Takeshita A; Muroi K
    Transfus Apher Sci; 2018 Dec; 57(6):746-751. PubMed ID: 30224152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality assessment and transfusion efficacy of buffy coat-derived platelet concentrates washed with platelet additive solution.
    Fernández-Muñoz H; Castilla-Llorente C; Plaza EM; Martínez-Millán C; Heras I; Iniesta P; Amigo ML; Ferrer-Marin F; Candela MJ; Lozano ML; Vicente V; Rivera J
    Blood Transfus; 2018 May; 16(3):273-278. PubMed ID: 28488971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in adverse transfusion reactions with increased use of washed platelet concentrates in Japan-A retrospective multicenter study.
    Ikebe E; Matsuoka S; Tanaka A; Yonemura Y; Fujii Y; Ohsaka A; Okazaki H; Kitazawa J; Ohtani S; Nakayama T; Momose SY; Miwa I; Taira R; Toyota K; Kino S; Kato H; Hamaguchi I
    Transfus Apher Sci; 2019 Apr; 58(2):162-168. PubMed ID: 30670326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential protein expression of blood platelet components associated with adverse transfusion reactions.
    Aloui C; Barlier C; Claverol S; Fagan J; Awounou D; Tavernier E; Guyotat D; Hamzeh-Cognasse H; Cognasse F; Garraud O; Laradi S
    J Proteomics; 2019 Mar; 194():25-36. PubMed ID: 30590131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated pathways and differentially expressed proteins associated with adverse transfusion reactions in different types of platelet components.
    Aloui C; Barlier C; Awounou D; Thiam S; Fagan J; Claverol S; Tavernier E; Mounier C; Hamzeh-Cognasse H; Cognasse F; Garraud O; Laradi S
    J Proteomics; 2020 Apr; 218():103717. PubMed ID: 32088354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of platelet additive solution-E stored platelet concentrates.
    Spelmink SE; Jager ST; van de Watering L; van der Meer PF; van Gammeren AJ; Wiersum-Osselton JC; Klei TRL; Kerkhoffs JH;
    Transfusion; 2023 Dec; 63(12):2273-2280. PubMed ID: 37909172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.